NF-κB remains a central target in the fight against inflammatory and immune-mediated diseases
24 July 2026
A new review highlights the pivotal role of the nuclear factor kappa B (NF-κB) signalling pathway in regulating immunity and inflammation, while examining emerging strategies to therapeutically target this master regulator… Read More…









